Alkermes plc (ALKS)
Healthcare • Drug Manufacturers - Specialty & Generic
StockNasdaqGSIrelandIE00B56GVS15
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Alkermes plc, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 15:15. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 24 Feb 2027 08:00 | — | — | — | Upcoming |
| 03 Nov 2026 08:00 | 0.25 | 0.57 | +130.9% | Beat |
| 28 Jul 2026 07:00 | 0.29 | 0.70 | +141.3% | Beat |
| 05 May 2026 07:00 | -0.04 | 0.38 | +1,053.0% | Beat |
| 25 Feb 2026 07:00 | 0.45 | 0.48 | +7.7% | Beat |
| 28 Oct 2025 07:00 | 0.39 | 0.65 | +68.5% | Beat |
| 29 Jul 2025 07:00 | 0.40 | 0.68 | +71.1% | Beat |
| 01 May 2025 07:00 | 0.24 | 0.29 | +18.9% | Beat |
| 12 Feb 2025 07:00 | 0.76 | 1.05 | +37.6% | Beat |
| 24 Oct 2024 07:00 | 0.71 | 0.73 | +2.4% | Beat |
| 24 Jul 2024 07:00 | 0.71 | 0.70 | -0.8% | In line |
| 01 May 2024 07:00 | 0.58 | 0.43 | -26.2% | Miss |
| 15 Feb 2024 07:00 | 0.46 | 0.22 | -52.0% | Miss |
| 25 Oct 2023 07:00 | 0.43 | 0.64 | +50.2% | Beat |
| 26 Jul 2023 07:00 | 0.64 | 0.55 | -13.8% | Miss |
| 26 Apr 2023 07:00 | -0.01 | 0.01 | +180.0% | Beat |
| 16 Feb 2023 07:00 | 0.05 | 0.14 | +210.8% | Beat |
| 02 Nov 2022 07:00 | 0.03 | 0.02 | -32.8% | Miss |
| 27 Jul 2022 07:00 | 0.05 | 0.06 | +26.7% | Beat |
| 27 Apr 2022 07:00 | 0.03 | 0.12 | +380.0% | Beat |
| 16 Feb 2022 07:00 | 0.13 | 0.23 | +72.5% | Beat |
| 27 Oct 2021 07:00 | 0.10 | 0.14 | +46.3% | Beat |
| 28 Jul 2021 07:00 | 0.12 | 0.30 | +142.4% | Beat |
| 28 Apr 2021 07:00 | -0.02 | 0.11 | +718.7% | Beat |
| 11 Feb 2021 07:00 | 0.07 | 0.10 | +43.8% | Beat |
| 29 Oct 2020 07:00 | — | 0.26 | +12,900.0% | Beat |
| 29 Jul 2020 07:00 | — | 0.06 | +4,411.3% | Beat |
| 29 Apr 2020 08:00 | -0.05 | 0.01 | +122.0% | Beat |
| 13 Feb 2020 07:00 | 0.66 | 0.83 | +26.4% | Beat |
| 23 Oct 2019 07:00 | -0.21 | -0.04 | +80.6% | Beat |
| 25 Jul 2019 07:00 | -0.12 | 0.09 | +176.9% | Beat |
| 25 Apr 2019 07:00 | -0.17 | -0.17 | -0.6% | In line |
| 14 Feb 2019 07:00 | -0.05 | 0.34 | +724.1% | Beat |
| 23 Oct 2018 07:00 | -0.08 | 0.07 | +192.9% | Beat |
| 26 Jul 2018 07:00 | 0.13 | 0.29 | +116.0% | Beat |
| 26 Apr 2018 07:00 | -0.09 | -0.09 | +4.8% | Beat |
| 14 Feb 2018 07:00 | 0.27 | 0.31 | +16.6% | Beat |
| 26 Oct 2017 07:00 | -0.01 | 0.03 | +494.7% | Beat |
| 27 Jul 2017 07:00 | -0.01 | 0.01 | +167.8% | Beat |
| 27 Apr 2017 07:00 | -0.09 | -0.18 | -99.3% | Miss |
| 15 Feb 2017 07:00 | 0.05 | 0.15 | +174.8% | Beat |
| 02 Nov 2016 07:00 | -0.04 | -0.09 | -154.7% | Miss |
| 28 Jul 2016 07:00 | -0.10 | -0.01 | +90.0% | Beat |
| 28 Apr 2016 07:00 | -0.20 | -0.16 | +21.5% | Beat |
| 25 Feb 2016 07:00 | -0.24 | -0.15 | +38.0% | Beat |
| 29 Oct 2015 07:00 | -0.21 | -0.18 | +14.4% | Beat |
| 30 Jul 2015 07:00 | -0.10 | -0.09 | +5.8% | Beat |
| 30 Apr 2015 07:00 | -0.05 | 0.06 | +230.9% | Beat |
| 24 Feb 2015 07:00 | 0.04 | 0.11 | +160.9% | Beat |
| 29 Oct 2014 07:00 | 0.02 | 0.03 | +44.7% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 1.5B | -5.2% | 241.7M | 16.4% | 1.43 | -34.1% | 480.3M |
| 2024 | 1.6B | -6.4% | 367.1M | 23.6% | 2.17 | +3.3% | 405.6M |
| 2023 | 1.7B | +49.6% | 355.8M | 21.4% | 2.10 | +316.5% | 353.3M |
| 2022 | 1.1B | — | -158.3M | -14.2% | -0.97 | — | -17.2M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 45.59 | 48.30 | 44.07 | 46.45 | +2.44% | 17,267,817 | |
| Oct 2026 | 40.00 | 46.38 | 38.98 | 45.34 | +11.90% | 42,656,600 | |
| Sep 2026 | 47.00 | 48.74 | 39.84 | 40.52 | -13.77% | 46,145,600 | |
| Aug 2026 | 48.58 | 51.66 | 46.46 | 46.99 | -4.08% | 28,596,300 | |
| Jul 2026 | 52.33 | 55.67 | 47.66 | 48.99 | -6.51% | 39,351,500 | |
| Jun 2026 | 42.19 | 55.28 | 40.62 | 52.40 | +24.20% | 57,970,600 | |
| May 2026 | 33.42 | 42.83 | 33.12 | 42.19 | +25.16% | 45,692,300 | |
| Apr 2026 | 35.81 | 36.48 | 32.47 | 33.71 | -4.67% | 41,844,100 | |
| Mar 2026 | 29.29 | 36.22 | 27.00 | 35.36 | +17.48% | 61,581,400 | |
| Feb 2026 | 33.54 | 35.34 | 29.81 | 30.10 | -11.18% | 35,403,900 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Alkermes Showcases Research From Psychiatry and Sleep Portfolios at the Neuroscience Education Institute Fall Congress (opens in a new tab) 05 Nov 2026 12:00
- Alkermes plc 2026 Q3 - Results - Earnings Call Presentation (opens in a new tab) SeekingAlpha · 05 Nov 2026 02:04
- Alkermes (ALKS) Stock Could Be Overvalued Following ALKS 7290 Trial Launch (opens in a new tab) Simply Wall St. · 04 Nov 2026 12:15
- RBC Capital Maintains Outperform on Alkermes, Raises Price Target to $57 (opens in a new tab) Benzinga · 04 Nov 2026 12:11
- Wells Fargo Maintains Overweight on Alkermes, Raises Price Target to $68 (opens in a new tab) Benzinga · 04 Nov 2026 11:41
- HC Wainwright & Co. Maintains Neutral on Alkermes, Raises Price Target to $50 (opens in a new tab) Benzinga · 04 Nov 2026 08:37
- Alkermes PLC (ALKS) Q3 2026 Earnings Call Highlights: Proprietary Sales Surge 31% as Orexin ... (opens in a new tab) GuruFocus.com · 04 Nov 2026 03:04
- Alkermes (ALKS) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 03 Nov 2026 21:28
- Alkermes to Present at Upcoming Investor Conferences (opens in a new tab) 03 Nov 2026 21:00
- Alkermes plc (ALKS) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 03 Nov 2026 19:15
- What Alkermes (ALKS) Said on Its Q3 Earnings Call (opens in a new tab) MarketBeat · 03 Nov 2026 18:14
- Alkermes plc Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 03 Nov 2026 17:49
- Alkermes (ALKS) Reports Q3 Earnings: What Key Metrics Have to Say (opens in a new tab) Zacks · 03 Nov 2026 13:30
- Alkermes (ALKS) Surpasses Q3 Earnings and Revenue Estimates (opens in a new tab) Zacks · 03 Nov 2026 12:15
- Alkermes: Q3 Earnings Snapshot (opens in a new tab) Associated Press · 03 Nov 2026 12:12
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 46.98 USD
- Market cap
- 7.8B
- Exchange
- NasdaqGS
- Country
- Ireland
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow ALKS and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.